| Literature DB >> 32158607 |
Madhusmita Borthakur1, Arun Bahadur Gurung2, Atanu Bhattacharjee2, S R Joshi1.
Abstract
Meghalaya, (in India), in the region of the mega-biodiversity hotspots, is home to a plethora of wild mushrooms. The present study concerns the exploration of the order Agaricales, which includes rare gilled mushrooms considered endangered under IUCN A4c criteria, due to the declining habitat. Electron microscopy of the gill sections revealed an abundance of clamp connections, hyphal cell walls, cystidia, and basidia. This rare species which belongs to the family Cyphellaceae, exhibits morphological and molecular differences from the Cyphella spp. Phylogenetic analysis revealed that it formed a clade under the genus Campanophyllum of the order Agaricales, confirmed by both Neighbor Joining (NJ) and Bayesian phylogenetic analysis. Being nutritionally potent along with its efficient antioxidant value, the fungal extract shows significant rise of two-fold in the antimicrobial activity along with the commercial antibiotics. The compound, Phenol, 2, 4-bis (1, 1-Dimethylethyl) (2, 4-DTBP) showed in ample range in the fungal extract along with aliphatic hydrocarbons, terpene, alcohol and volatile organic compounds on further characterization in GCMS. The present study indicates the endangered Campanophyllum proboscideum could be a rich source of natural antioxidants and an effective pharmaceutical agent.Entities:
Keywords: Campanophyllum; microscopic; molecular; nutritional; phylogeny
Year: 2020 PMID: 32158607 PMCID: PMC7048233 DOI: 10.1080/12298093.2020.1723388
Source DB: PubMed Journal: Mycobiology ISSN: 1229-8093 Impact factor: 1.858
Figure 1.(A) Fresh basidiomycota of Campanophyllum proboscideum; (B) mycelia morphology showing cystidia with tapering end; (C) cystidia with globular end; (D) clamp connection; (E) Globular basidia formation observed in the transverse section of gills; (F) Scanning electron micrograph of gills showing globular end; (G) Scanning electron micrograph of gills with hymenium; (H) Scanning electron micrograph of gills showing clamp connection.
Figure 2.Bayesian tree inferred from ITS nucleotide sequence with 1 posterior probability.
Nutritional profiling of Campanophyllum proboscidium (g/100g).
| Moisture (%) | Fiber | Fat | Ash | Protein |
|---|---|---|---|---|
| 56.78 ± 0.13 | 5.78 ± 0.43 | 0.7 ± 0.03 | 2.87 ± 0.18 | 21.67 ± 0.67 |
Result considered was the mean ± SEM of 3 trials (one-way ANOVA).
Figure 3.(A) Free radical scavenging activity of the methanolic extract at various concentrations; (B) Reducing power activity of the mushroom methanolic extract at various concentrations.
Bioactive compound profiling of Campanophyllum proboscidium.
| Total flavonoids (mg QE/g dry weight) | Total phenolics (mg GAE/g dry weight) | β-carotene (µg/g) | Lycopene (µg/g) |
|---|---|---|---|
| 0.94 ± 0.037 | 0.5127 ± 0.020 | 7.42 ± 0.04 | 3.84 ± 0.02 |
Result considered was the mean ± SEM of 3 trials (one way ANOVA).
Figure 4.Total ionic count of the mushroom metabolic by GCMS.
GCMS profiling of Campanophyllum proboscidium.
| RT (min) | Compounds (Identified) | Mol. formula | Peak abundance (%) | Activity | |
|---|---|---|---|---|---|
| 11.6 | 2H-Pyran, Tetrahydro-4-methyl-2-(2-methyl-1-propenyl)- | C10H18O | 154 | 1.5 | Flavoring agent |
| 13.25 | 2-methylsulfanyl-1-(thiomorpholin-4-yl) Ethanone | C7H13NOS2 | 191.30 | 100 | – |
| 13.25 | Phenol, 2, 6bis (1, 1-Dimethylethyl) - | C14H22O | 206 | 12.5 | Anti-inflammatory |
| 13.27 | Phosphetane, 1, 1-bis (1, 1-dimethyethyl) 1-fluoro-1, 1-dihydro | C11H24FP | 206 | 7.5 | – |
| 14.18 | Cyclohexadecane | C16H32 | 224 | 2.0 | – |
| 16.4 | 2, 6-dimethoxybenzoquinone | C8H8O4 | 168 | 1.5 | Toxic (mutagenic, cytotoxic, hepatotoxic) |
| 17.04 | 3-methyl-2-(2-oxopropyl) furan | C8H10O2 | 138 | 1.02 | Anti-inflammatory, antipyretic, hepatoprotective |
| 17.6 | 2-hydroxy-4-methylthiobutanoate | C5H9O3S | 149.18 100 | – | |
| 18.3 | 1-Eicosene | C20H40 | 280 | 2.5 | Anti-diabetic, anti-cancer |
| 19.12 | S-propyl N-butyl-N-ethylcarbamothiote | C10H21NOS | 203.13 | 0.5 | – |
| 19.12 | 1-Methyl-1-histidine, trimethylsilyl ester | C10H19N3O2Si | 241 | 0.8 | – |
| 19.12 | Sarcosine, n-pentafluoropropionyl-, propyl ester | C9H12F5NO3 | 277 | 0.3 | – |
| 20.29 | - (–) Epicatechin | C5H14O6 | 207.1043 | 3.25 | Antioxidant |
Antimicrobial and synergistic activity of the metabolite against pathogens Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes and Klebsiella pneumoniae.
| Clinical pathogens | Zone of inhibition (in mm) | Antibiotic [Chloramphenicol] A | Metabolite + Antibiotic Zone of inhibition (in mm) | Fold area increase (%) (B2−A2)/ A2 × 100 A-Antibiotic (ZOI) B-Antibiotic + metabolite |
|---|---|---|---|---|
| 10 mm | 32 | 33 | 6.34 | |
| 12 mm | 31 | 32 | 6.55 | |
| >10 | 32 | 36 | 26.56 | |
| >10 | 31 | 32 | 6.55 |